Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 NOK)

NET PROFIT (x1000 NOK)

EMPLOYEES

Share

Scandinavian Biopharma Holding AB

Closing information (x1000 NOK)

Closing information 2024/12 (consolidated) 2023/12 (consolidated) 2022/12 (consolidated)
Turnover 165,990 Less Arrow 156,394 Less Arrow 115,203
Financial expenses 34 Less Arrow 16 More Arrow 481
Earnings before taxes 997 Less Arrow 695 Less Arrow 215
EBITDA 552 Less Arrow -365 More Arrow 1,222
Total assets 118,603 More Arrow 126,100 Less Arrow 113,807
Current assets 115,041 More Arrow 122,976 Less Arrow 111,953
Current liabilities 104,764 More Arrow 114,071 Less Arrow 99,524
Equity capital 13,839 Less Arrow 12,029 More Arrow 14,283
- share capital 261 Less Arrow 256 Less Arrow 239
Employees (average) 35 Less Arrow 30 Less Arrow 27

Financial ratios

Fiscal year 2024/12 (consolidated) 2023/12 (consolidated) 2022/12 (consolidated)
Solvency 11.7% Less Arrow 9.5% More Arrow 12.6%
Turnover per employee 4,743 More Arrow 5,213 Less Arrow 4,267
Profit as a percentage of turnover 0.6% Less Arrow 0.4% Less Arrow 0.2%
Return on assets (ROA) 0.9% Less Arrow 0.6% Equal arrow 0.6%
Current ratio 109.8% Less Arrow 107.8% More Arrow 112.5%
Return on equity (ROE) 7.2% Less Arrow 5.8% Less Arrow 1.5%
Change turnover 6,777 More Arrow 33,017 Less Arrow 26,474
Change turnover % 4% More Arrow 27% More Arrow 30%
Chg. No. of employees 5 Less Arrow 3 Less Arrow 2
Chg. No. of employees % 17% Less Arrow 11% Less Arrow 8%

Total value of public sale

Fiscal year 2024/12 (consolidated) 2023/12 (consolidated) 2022/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.